Glycans in Drug Design
Glycans are components of many bio-therapeutic agents, ranging from natural products to molecules based on rational design to recombinant glycoproteins. The glycan components of these agents can be important determinants of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology involves a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some other plant proteins that are capable of interacting with endogenous or foreign (macro) molecules.
Related Conference of Glycans in Drug Design
Glycans in Drug Design Conference Speakers
Recommended Sessions
- Glyco-Biomarkers
- Genomics
- Glycans in Diseases and Therapeutics
- Glycans in Drug Design
- Glycans in Genetic Disorders
- Glyco Immunology
- Glyco-Bioinformatics
- Glyco-proteomics
- Glycobiology
- Glycobiology and Biotechnology
- Glycobiology and Structural biology
- Glycobiology in Personalized Medicine
- Glycomics and Metabolomics
- Glycoprotein Technologies
- Mass Spectrometry